Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  MannKind Corporation    

SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

MannKind Corporation : MNKD, MU, ALXN and GMCR added to NASDAQ Active Stock Watch List at EPR

share with twitter share with LinkedIn share with facebook
share via e-mail
0
07/16/2013 | 03:05pm CEST

New York, NY - (ACCESSWIRE) - 07/16/2013 - Equity Profile Report initiates its NASDAQ Active Stock Watch List adding MannKind Corp. (NASDAQ:MNKD), Micron Technology Inc. (NASDAQ:MU), Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Green Mountain Coffee Roasters, Inc. (NASDAQ:GMCR),

MannKind Corp. (NASDAQ:MNKD) a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States closed up in its previous session (+6.47%) on 7,469,136 shares traded. MannKind Corp. (NASDAQ:MNKD) is currently up (+310.99%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about MannKind Corp. (NASDAQ:MNKD)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=MNKD&SubId=AW

Micron Technology Inc. (NASDAQ:MU) a company that together with its subsidiaries, engages in manufacturing and marketing semiconductor devices worldwide closed up in its previous session (+2.99%) on 29,731,748 shares traded after Micron Technology Inc reported its Financials. Micron Technology Inc. (NASDAQ:MU) is currently up (+155.62%) from its recent 52-week low which has prompted Equity Profile Report to add the stock to their NASDAQ Active Stock Watch List and Investor Poll.

To find out what other Investors are saying about Micron Technology Inc. (NASDAQ:MU)

Click Here: http://www.equityprofilereport.com/Survey.aspx?stock=MU&SubId=AW

Also mentioned in Equity Profile Report?s NASDAQ Active Stock Watch List and Investor Poll was: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), Green Mountain Coffee Roasters, Inc. (NASDAQ:GMCR), Groupon, Inc. (NASDAQ:GRPN) and Zynga, Inc. (NASDAQ:ZNGA)

To see what other investors are saying about: ALXN, GMCR, GRPN, ZNGA

Click here: http://www.equityprofilereport.com/PR.aspx?stock=ALXN-GMCR-GRPN-ZNGA&SubId=AW

Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed. Timing is important when trading Small Caps and Penny Stocks.

Simply sign up for free and start receiving exclusive alerts.

Subscribe Here: http://www.Equityprofilereport.com

Disclosure: Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.

Contact Info:

Equity Profile Report

editor@Equityprofilereport.com


© Accesswire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on MANNKIND CORPORATION
08/17 MANNKIND : and One Drop Partner to Launch the A-One Clinical Trial
08/10 MANNKIND : Afrezza driving Mannkind results
08/09 MANNKIND : Featured Company News – MannKind and One Drop Announce Collabor..
08/09 MANNKIND CORPORATION : Featured Company News – MannKind and One Drop Announce Co..
08/08 MANNKIND : Takes Hit in Bottom Line, On Markets
08/08 MANNKIND : and One Drop Partner to Launch the A-ONE Clinical Trial
08/08 MANNKIND : reports 2Q loss
08/07 MANNKIND : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESUL..
08/07 MANNKIND CORPORATION (NASDAQ : MNKD) Files An 8-K Results of Operations and Fina..
08/07 MANNKIND CORP : Results of Operations and Financial Condition (form 8-K)
More news
News from SeekingAlpha
03/06 Midday Gainers / Losers
03/06 HEALTHCARE - TOP GAINERS / LOSERS AS : 00 am
03/06 MannKind - Afrezza Sales Struggle As February Comes To A Close
03/03 MANNKIND ENACTS REVERSE SPLIT AT 1-F : What Investors Need To Consider
03/03 Post-split trading in MannKind commences today
Financials ($)
Sales 2017 11,6 M
EBIT 2017 -93,9 M
Net income 2017 -93,6 M
Finance 2017 160 M
Yield 2017 -
P/E ratio 2017 -
P/E ratio 2018
Capi. / Sales 2017 -1,07x
Capi. / Sales 2018 7,89x
Capitalization 148 M
Technical analysis trends MANNKIND CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
 
Mean consensus HOLD
Number of Analysts 2
Average target price 4,00 $
Spread / Average Target 184%
EPS Revisions
Managers
NameTitle
Michael E. Castagna Chief Executive Officer & Director
Kent Kresa Chairman
Steven Binder Chief Financial Officer & Chief Accounting Officer
Raymond W. Urbanski Chief Medical Officer & Vice President
Joseph Kocinsky Chief Technology Officer & Vice President
Sector and Competitors
1st jan.Capitalization (M$)
MANNKIND CORPORATION148
AMGEN14.42%122 702
CELGENE CORPORATION10.09%99 695
GILEAD SCIENCES0.70%94 810
REGENERON PHARMACEUTICALS27.48%50 334
VERTEX PHARMACEUTICALS102.27%37 568